Su H. Wang

484 total citations · 1 hit paper
5 papers, 258 citations indexed

About

Su H. Wang is a scholar working on Epidemiology, Hepatology and Health. According to data from OpenAlex, Su H. Wang has authored 5 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Hepatology and 1 paper in Health. Recurrent topics in Su H. Wang's work include Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Su H. Wang is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). Su H. Wang collaborates with scholars based in United States and Canada. Su H. Wang's co-authors include Chau Trinh‐Shevrin, Erin E. Conners, Dawn L. Hershman, Banu Symington, Jessica Hwang, Noele P. Nelson, Henry Pollack, David L. Thomas, Simona C. Kwon and Andrew Artz and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Su H. Wang

5 papers receiving 254 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023

2023 115 citations Erin E. Conners, Lakshmi Panagiotakopoulos et al. PubMed Central profile →

Peers

Su H. Wang

EPIDE

HEPAT

ONCOL

ID

SURGE

Sruthi Yekkaluri United States

Thomas L. Jeffers United States

Lisa Quirk United States

Penda Suso Gambia

Sonali Paul United States

Vanessa Wu China

U. Lorenzoni Italy

Lóa Davíðsdóttir Sweden

Rikita Hatia United States

Francisco Fuster García Spain

Sruthi Yekkaluri United States

Su H. Wang

187 ×0.9

EPIDE

195 ×1.1

HEPAT

68 ×1.6

ONCOL

73 ×3.6

ID

20 ×1.2

SURGE

Citations per year, relative to Su H. Wang Su H. Wang (= 1×) peers Sruthi Yekkaluri

Countries citing papers authored by Su H. Wang

Since Specialization

Citations

This map shows the geographic impact of Su H. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su H. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su H. Wang more than expected).

Fields of papers citing papers by Su H. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su H. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su H. Wang. The network helps show where Su H. Wang may publish in the future.

Co-authorship network of co-authors of Su H. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Su H. Wang. A scholar is included among the top collaborators of Su H. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su H. Wang. Su H. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Ghany, Marc G., Calvin Q. Pan, Anna S. Lok, et al.. (2025). AASLD IDSA Practice Guideline on treatment of chronic hepatitis B. Hepatology. 83(4). 974–997. 3 indexed citations

2.

Conners, Erin E., Lakshmi Panagiotakopoulos, Megan G. Hofmeister, et al.. (2023). Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023. PubMed Central. 72(1). 1–25. 115 indexed citations breakdown →

3.

Hwang, Jessica, Jordan J. Feld, Sarah P. Hammond, et al.. (2020). Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. Journal of Clinical Oncology. 38(31). 3698–3715. 96 indexed citations

4.

Xu, Binghong & Su H. Wang. (2020). Sa1515 NOVEL APPROACHES TO FIND THE MISSING MILLIONS: COMMUNITY AND EMERGENCY DEPARTMENT (ED) HEPATITIS B SCREENING WITH LINKAGE TO CARE IN AN INTEGRATED HEALTHCARE MODEL. Gastroenterology. 158(6). S–1317. 1 indexed citations

5.

Pollack, Henry, et al.. (2014). Chronic Hepatitis B and Liver Cancer Risks among Asian Immigrants in New York City: Results from a Large, Community-Based Screening, Evaluation, and Treatment Program. Cancer Epidemiology Biomarkers & Prevention. 23(11). 2229–2239. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact